Director
Disclosures on record
11
Companies involved
2
1 buy, median -16.8% vs S&P 500, beat it 0 of 1 time.
Average -16.8% vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed May 21, 2026 to May 21, 2026, measured from the first close after the filing. Past results, not a forecast.
Stock since the trade -9.4% · S&P 500 -0.8% · to Oct 1
A board member of Boston Scientific spent $100K of their very own money to buy Boston Scientific shares. 3 other people at Boston Scientific bought some too, in the same month. Their pile of Boston Scientific shares grew by 14%.
Stock since the trade -10.7% · S&P 500 +0.8% · to Oct 1
A board member of Boston Scientific spent $50K of their very own money to buy Boston Scientific shares. 3 other people at Boston Scientific bought some too, in the same month. Their pile of Boston Scientific shares grew by 8%.
Stock since the trade -11.9% · S&P 500 -0.9% · to Oct 1
A board member of Boston Scientific spent $6.8K of their very own money to buy Boston Scientific shares. 3 other people at Boston Scientific bought some too, in the same month.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Stock since the trade -23.9% · S&P 500 +4.1% · to Oct 1
A board member of Boston Scientific spent $125K of their very own money to buy Boston Scientific shares. 2 other people at Boston Scientific bought some too, in the same month. Their pile of Boston Scientific shares grew by 23%.
Stock since the trade -23.7% · S&P 500 +3.1% · to Oct 1
A board member of Boston Scientific spent $126K of their very own money to buy Boston Scientific shares. 2 other people at Boston Scientific bought some too, in the same month. Their pile of Boston Scientific shares grew by 19%.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
